Van Echo Da
- Oncology top 10%
- Cancer Treatment and Pharmacology 5
- Lung Cancer Research Studies 4
- Peptidase Inhibition and Analysis 2
-
- Neuroendocrine Tumor Research Advances 3
-
- Acute Myeloid Leukemia Research 3
-
- Glutathione Transferases and Polymorphisms 2
-
- Chronic Lymphocytic Leukemia Research 2
-
- Neurological diseases and metabolism 1
- Co-authors
- Wiernik PhJoseph AisnerMargaret WhitacreHenderson EsMartin LevittHarvey SchipperRosemarie Mick
- Cited by
- OncologyEpidemiologyHematology
- Journals
- PubMed (18 papers)
- Partner nations
- United States
In The Last Decade
Van Echo Da
18 papers receiving 343 citations
Peers
Comparison fields: 5 of 48
- Oncology 290
- Epidemiology 177
- Hematology 50
- Pulmonary and Respiratory Medicine 138
- Pathology and Forensic Medicine 46
Countries citing papers authored by Van Echo Da
This map shows the geographic impact of Van Echo Da's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Van Echo Da with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Van Echo Da more than expected).
Fields of papers citing papers by Van Echo Da
This network shows the impact of papers produced by Van Echo Da. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Van Echo Da. The network helps show where Van Echo Da may publish in the future.
Co-authorship network
The 7 scholars most cited alongside Van Echo Da, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Phase II study of deoxydoxorubicin in patients with advanced liver cancer. | 1987 | 2 |
| 2 | Phase II trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study. | 1986 | 16 |
| 3 | Phase I clinical and pharmacologic trial of carboplatin daily for 5 days. | 1984 | 60 |
| 4 | Phase I-II trial of anthracenedicarboxaldehyde in patients with refractory adult acute leukemia. | 1984 | 3 |
| 5 | Value of prophylactic cranial irradiation given at complete remission in small cell lung carcinoma. | 1983 | 90 |
| 6 | Treatment of advanced non-small cell lung cancer with bisantrene. | 1983 | 3 |
| 7 | Combination chemotherapy for small cell carcinoma of the lung: continuous versus alternating non-cross-resistant combinations. | 1982 | 107 |
| 8 | Phase II evaluation of AMSA in patients with stage III--IV malignant melanoma. | 1982 | 5 |
| 9 | Phase I trial of aclacinomycin A. | 1982 | 8 |
| 10 | CCNU, vincristine, methotrexate, and procarbazine treatment of relapsed small cell lung carcinoma. | 1982 | 16 |
| 11 | Phase II trial of methyl-G (methylglyoxal bis-guanylhydrazone) in patients with metastatic renal cell carcinoma. | 1981 | 4 |
| 12 | Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma. | 1981 | 5 |
| 13 | Phase I trial of dihydroxyanthracenedione. | 1981 | 9 |
| 14 | High-dose VP 16-213 (NSC 141540) for the treatment of patients with previously treated acute leukemia. | 1980 | 21 |
| 15 | Phase II evaluation of N-(phosphonacetyl)-L-aspartic acid (PALA) in metastatic adenocarcinoma of the colon or rectum. | 1980 | 12 |
| 16 | Phase I trial of pentamethylmelamine in patients with previously treated malignancies. | 1980 | 7 |
| 17 | Phase I study of neocarzinostatin in patients with acute leukemia. | 1978 | 8 |
| 18 | Vinblastine, 5-azacytidine, and VP-16-213 therapy for previously treated patients with acute nonlymphocytic leukemia. | 1977 | 17 |
About Van Echo Da
Van Echo Da is a scholar working on Hematology, Oncology, Genetics, Neurology and Biotechnology, having authored 18 papers that have together received 393 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Lung Cancer Research Studies (4 papers), Acute Myeloid Leukemia Research (3 papers), Neuroendocrine Tumor Research Advances (3 papers), Glutathione Transferases and Polymorphisms (2 papers), Chronic Lymphocytic Leukemia Research (2 papers), Peptidase Inhibition and Analysis (2 papers) and Neurological diseases and metabolism (1 paper). The work is most often cited by research in Oncology (290 citations), Epidemiology (177 citations), Hematology (50 citations), Pulmonary and Respiratory Medicine (138 citations) and Pathology and Forensic Medicine (46 citations). Van Echo Da has collaborated with scholars based in United States. Frequent co-authors include Wiernik Ph, Joseph Aisner, Margaret Whitacre, Henderson Es, Martin Levitt, Harvey Schipper and Rosemarie Mick. Their work appears in journals such as PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.